OMX Nordic 40
|
2 714,19
|
3,98
|
0,15 %
|
Analysen zu OMX Nordic 40-Werten
| 31.01.24 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 31.01.24 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 31.01.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 31.01.24 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Hennes & Mauritz AB Neutral | UBS AG | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Nokia Buy | Deutsche Bank AG | |
| 30.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.01.24 | Volvo AB Buy | Deutsche Bank AG | |
| 30.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 29.01.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
| 29.01.24 | Nokia Hold | Jefferies & Company Inc. | |
| 26.01.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
| 26.01.24 | Volvo AB Sector Perform | RBC Capital Markets | |
| 26.01.24 | Volvo AB Sell | UBS AG | |
| 25.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Nokia Underweight | Barclays Capital | |
| 25.01.24 | Nokia Neutral | UBS AG | |
| 25.01.24 | Nokia Hold | Jefferies & Company Inc. | |
| 25.01.24 | Volvo AB Sell | UBS AG | |
| 25.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 24.01.24 | Nokia Neutral | JP Morgan Chase & Co. |